Merola JF, Conrad C, Hampton P, Lambert J, Gottlieb AB, Tilt N, Cross N, Wiegratz S, Gooderham M. Bimekizumab 3-year Efficacy in High-Impact Areas in Moderate to Severe Plaque Psoriasis: Pooled Results from Five Phase 3/3b Trials. J of Skin [Internet]. 2024 Jan. 16 [cited 2024 Jul. 3];8(1):s304. Available from: https://jofskin.org/33014/index.php/skin/article/view/2446